New STEAP1-targeted antibody drug conjugate boosts immune response against prostate cancer
Prostate cancer that stops responding to androgen receptor–targeted therapies remains one of the most lethal challenges in oncology, and a ...
Prostate cancer that stops responding to androgen receptor–targeted therapies remains one of the most lethal challenges in oncology, and a ...
UCLA researchers have identified a way to make antibody-drug conjugates more powerful against metastatic castration-resistant prostate cancer, an advanced form ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine